Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial

BACKGROUND: When chemotherapy is indicated in patients with early breast cancer, regimens that contain anthracyclines and taxanes are established standard treatments. Gemcitabine has shown promising effects on the response and prognosis in patients with metastatic breast cancer. The SUCCESS-A trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: de Gregorio, Amelie, Häberle, Lothar, Fasching, Peter A., Müller, Volkmar, Schrader, Iris, Lorenz, Ralf, Forstbauer, Helmut, Friedl, Thomas W. P., Bauer, Emanuel, de Gregorio, Nikolaus, Deniz, Miriam, Fink, Visnja, Bekes, Inga, Andergassen, Ulrich, Schneeweiss, Andreas, Tesch, Hans, Mahner, Sven, Brucker, Sara Y., Blohmer, Jens-Uwe, Fehm, Tanja N., Heinrich, Georg, Lato, Krisztian, Beckmann, Matthias W., Rack, Brigitte, Janni, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583247/
https://ncbi.nlm.nih.gov/pubmed/33097092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01348-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados